Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Miley Cyrus flashes a diamond ring on the red carpet, sparking engagement rumors with Maxx Morando: A timeline of their four-year relationship - 2Vote In favor of Your Favored Pizza Cover
- 3NASA's giant moon rocket, in photos
- 4In a first, scientists observe a comet reversing its spin
- 5This Huge Ocean Beast Shifts Sharks’ Evolutionary Timeline
- Global measles cases drop 71% in 24 years as vaccination coverage improves, WHO says
- Bolsonaro briefly leaves Brazilian prison for medical tests after a fall from his bed
- Virtual reality opens doors for older people to build closer connections in real life
- Sheinelle Jones will cohost fourth hour of 'Today' with Jenna Bush Hager: Here's what to know about her
- Israel says soldiers wounded in Gaza fighting amid fragile truce
- 'Dancing with the Stars' semifinals: How to watch Episode 10 tonight, where to stream, who's left and more
- the Kinds of Thailand: Decision in favor of Your Number one Thai Dish!
- Nodding off is dangerous. Some animals have evolved extreme ways to sleep in precarious environments
- Free Fuel Giveaway Sparks Traffic Mayhem Before Police Shut It Down
